Mainz Biomed

Inactive

MYNZ (NGM)

Mainz Biomed N.V. develops and sells in vitro diagnostic tests for early cancer detection in the United States and Europe. Its ColoAlert stool-based molecular test screens for colorectal cancer, and PancAlert targets pancreatic cancer screening. The company runs a clinical diagnostic laboratory and distributes its IVD kits to third‑party labs. It has a collaboration with Thermo Fisher Scientific on colorectal cancer screening products. Founded in 2008, based in Mainz, Germany.